Effects of estrogen therapy and aerobic training on sympathetic activity and hemodynamics in healthy postmenopausal women: A double-blind randomized trial

Menopause

Volumn 21, Issue 4, 2014, Pages 369-375

  Oneda, Bruna ^a   Cardoso, Crivaldo G ^b,c   Forjaz, Cláudia L M ^b   Araújo, Tatiana G ^a   Bernardo, Fernanda R ^a   De Gusmão, Josiane Lima ^a   Pinto, Luiz Gustavo ^b   Labes, Eliana ^b   Abrahão, Sandra B ^a   Mion, Décio ^a   Fonseca, Angela M ^b   Tinucci, Taís ^a,b  

^a Hypertension Unit General Hospital   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Blood flow; Blood pressure; Exercise; Heart rate; Hormone therapy; Menopause

Indexed keywords

ESTRADIOL VALERATE; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; PLACEBO; ESTRADIOL;

ADULT; AEROBIC EXERCISE; ANALYSIS OF VARIANCE; ARTICLE; BICYCLE ERGOMETER; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; ESTROGEN THERAPY; FEMALE; FOREARM BLOOD FLOW; HEART RATE; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; HYSTERECTOMY; MICRONEUROGRAPHY; MIDDLE AGED; MUSCLE SYMPATHETIC NERVE ACTIVITY; NEUROGRAPHY; OSCILLOMETRY; OVARIECTOMY; OXYGEN CONSUMPTION; PLETHYSMOGRAPHY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL; REST; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; ADRENERGIC SYSTEM; ANALOGS AND DERIVATIVES; BLOOD PRESSURE; DRUG EFFECTS; EXERCISE; EXERCISE TEST; PHYSIOLOGY; PILOT STUDY;

BLOOD PRESSURE; DOUBLE-BLIND METHOD; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; EXERCISE; EXERCISE TEST; FEMALE; HEART RATE; HEMODYNAMICS; HUMANS; HYSTERECTOMY; MIDDLE AGED; OXYGEN CONSUMPTION; PILOT PROJECTS; PLACEBOS; POSTMENOPAUSE; SYMPATHETIC NERVOUS SYSTEM;

EID: 84897525738     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31829d2a00     Document Type: Article

References (47)

1. Barton M, Meyer MR, Haas E. Hormone replacement therapy and atherosclerosis in postmenopausal women: does aging limit therapeutic benefits? Arterioscler Thromb Vasc Biol 2007;27:1669-1672.
2. Dubey RK, Oparil S, Imthurn B, Jackson EK. Sex hormones and hypertension. Cardiovasc Res 2002;53:688-708.
3. Meyer MR, Haas E, Barton M. Gender differences of cardiovascular disease: new perspectives for estrogen receptor signaling. Hypertension 2006;47:1019-1026.
4. Guyton AC,Hall JE. Text Book of Medical Physiology, 10th ed. Philadelphia, PA: Saunders Company, 2000.
5. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statisticsV2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
6. Arnal JF, Laurell H, Fontaine C, et al. Estrogen receptor actions on vascular biology and inflammation: implications in vascular pathophysiology. Climacteric 2009;12(suppl 1):12-17.
7. Pripp U, Hall G, Csemiczky G, Eksborg S, Landgren BM, Schenck-Gustafsson K. A randomized trial on effects of hormone therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease. J Hypertens 1999;17:1379-1386.
8. Schunkert H, Danser AH, Hense HW, Derkx FH, Kurzinger S, Riegger GA. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39-45.
9. Cacciatore B, Paakkari I, Hasselblatt R, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol 2001;184:904-909.
10. Chiu CL, Lujic S, Thornton C, et al. Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort study. PLoS One 2012;7:e40260.
11. Cardoso CG Jr, Rosas FC, Oneda B, et al. Aerobic training abolishes ambulatory blood pressure increase induced by estrogen therapy: a double blind randomized clinical trial. Maturitas 2011;69:189-194.
12. Sudhir K, Elser MD, Jennings GL, Komesaroff PA. Estrogen supplementation decreases norepinephrine-induced vasoconstriction and total body norepinephrine spillover in perimenopausal women. Hypertension 1997;30:1538-1543.
13. Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001;103:2903-2908.
14. Hunt BE, Taylor JA, Hamner JW, Gagnon M, Lipsitz LA. Estrogen replacement therapy improves baroreflex regulation of vascular sympathetic outflow in postmenopausal women. Circulation 2001;103:2909-2914.
15. De Meersman RE, Zion AS, Giardina EG, Weir JP, Lieberman JS, Downey JA. Estrogen replacement, vascular distensibility, and blood pressures in postmenopausal women. Am J Physiol 1998;274(5 pt 2): H1539-H1544.
16. Huikuri HV, Pikkujamsa SM, Airaksinen KE, et al. Sex-related differences in autonomic modulation of heart rate in middle-aged subjects. Circulation 1996;94:122-125.
17. Mishra N, Mishra VN, Devanshi. Exercise beyond menopause: do's and don'ts. J Midlife Health 2011;2:51-56.
18. Seccareccia F, Menotti A. Physical activity, physical fitness and mortality in a sample of middle aged men followed-up 25 years. J Sports Med Phys Fitness 1992;32:206-213.
19. Grassi G, Seravalle G, Calhoun DA, Mancia G. Physical training and baroreceptor control of sympathetic nerve activity in humans. Hypertension 1994;23:294-301.
20. Laterza MC, de Matos LD, Trombetta IC, et al. Exercise training restores baroreflex sensitivity in never-treated hypertensive patients. Hypertension 2007;49:1298-1306.
21. Ueno LM, Drager LF, Rodrigues AC, et al. Effects of exercise training in patients with chronic heart failure and sleep apnea. Sleep 2009;32:637-647.
22. Oneda B, Forjaz CL, Bernardo FR, et al. Low-dose estrogen therapy does not change postexercise hypotension, sympathetic nerve activity reduction, and vasodilation in healthy postmenopausal women. Am J Physiol Heart Circ Physiol 2008;295:H1802-H1808.
23. Halliwill JR, Taylor JA, Eckberg DL. Impaired sympathetic vascular regulation in humans after acute dynamic exercise. J Physiol 1996;495 (pt 1):279-288.
24. Bhambhani Y, Singh M. Ventilatory thresholds during a graded exercise test. Respiration 1985;47:120-128.
25. Mark AL,Wallin BG. Microneurography: a technique for assessing central neural effects of adrenergic drugs on sympathetic outflow in humans. J Cardiovasc Pharmacol 1985;(7 suppl 8):S67-S69.
26. Sundlof G, Wallin BG. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol 1977;272:383-397.
27. Mano GM, Souza VF, Pierin AM, et al. Assessment of the DIXTAL DX-2710 automated oscillometric device for blood pressure measurement with the validation protocols of the British Hypertension Society (BHS) and the Association for the Advancement of Medical Instrumentation (AAMI). Arq Bras Cardiol 2002;79:606-610, 1-5.
28. Siggaard-Andersen J. Venous occlusion plethysmography on the calf. Evaluation of diagnosis and results in vascular surgery. Dan Med Bull 1970;17(suppl I):1-68.
29. Duncan JJ, Farr JE, Upton SJ, Hagan RD, Oglesby ME, Blair SN. The effects of aerobic exercise on plasma catecholamines and blood pressure in patients with mild essential hypertension. JAMA 1985;254: 2609-2613.
30. Earnest CP, Lavie CJ, Blair SN, Church TS. Heart rate variability characteristics in sedentary postmenopausal women following six months of exercise training: the DREW study. PLoS One 2008;3:e2288.
31. Wang PH, Horng HC, Cheng MH, Chao HT, Chao KC. Standard and low-dose hormone therapy for postmenopausal womenVfocus on the breast. Taiwan J Obstet Gynecol 2007;46:127-134.
32. O'Sullivan AJ, Crampton LJ, Freund J, Ho KK. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 1998; 102:1035-1040.
33. Duanmu Z, Lapanowski K, Dunbar JC. Insulin-like growth factor-I decreases sympathetic nerve activity: the effect is modulated by glycemic status. Proc Soc Exp Biol Med 1997;216:93-97.
34. Ichikawa J, Sumino H, Ichikawa S, Ozaki M. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women. Am J Hypertens 2006;19:744-749.
35. Amaral SL, Zorn TM, Michelini LC. Exercise training normalizes wall-to-lumen ratio of the gracilis muscle arterioles and reduces pressure in spontaneously hypertensive rats. J Hypertens 2000;18: 1563-1572.
36. Arakawa K. Exercise, a measure to lower blood pressure and reduce other risks. Clin Exp Hypertens 1999;21:797-803.
37. Czarnecka D, Kawecka-Jaszcz K, Olszanecka A, et al. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. Med Sci Monit 2004;10:CR55-CR61.
38. Smolders RG, van der Mooren MJ, Kenemans P, van der Linden PW, Stehouwer CD, Sipkema P. 17A-Estradiol induces a rapid, endotheliumdependent, sex-specific vasodilatation in spontaneous constricted rat arterioles. Am J Obstet Gynecol 2002;187:375-381.
39. Kirwan LD, MacLusky NJ, Shapiro HM, Abramson BL, Thomas SG, Goodman JM. Acute and chronic effects of hormone replacement therapy on the cardiovascular system in healthy postmenopausal women. J Clin Endocrinol Metab 2004;89:1618-1629.
40. Vitale C, Mercuro G, Cerquetani E, et al. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008;28:348-352.
41. Novella S, Dantas AP, Segarra G, Medina P, Hermenegildo C. Vascular aging in women: is estrogen the fountain of youth? Front Physiol 2012;3:165.
42. Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc 2004;36:533-553.
43. Dickhuth HH, Lehmann M, Auch-Schwelk W, Meinertz T, Keul J. Physical training, vegetative regulation, and cardiac hypertrophy. J Cardiovasc Pharmacol 1987;10(suppl 6):S71-S78.
44. Cornelissen VA, Verheyden B, Aubert AE, Fagard RH. Effects of aerobic training intensity on resting, exercise and post-exercise blood pressure, heart rate and heart-rate variability. J Hum Hypertens 2010;24:175-182.
45. Rosano GM, Patrizi R, Leonardo F, et al. Effect of estrogen replacement therapy on heart rate variability and heart rate in healthy postmenopausal women. Am J Cardiol 1997;80:815-817.
46. Kjekshus JK. Importance of heart rate in determining A-blocker efficacy in acute and long-term acute myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-49F.
47. Rodrigues AD, Theodoro H, Mendes KG, Paniz VM, de Lorenzi D, Anselmo Olinto MT. Factors associated with metabolic syndrome in climacteric women of southern Brazil. Climacteric 2013;16:96-103.